Erythropoietin claims monitoring policy: implications of the October 2006 update continuing.

@article{Messana2006ErythropoietinCM,
  title={Erythropoietin claims monitoring policy: implications of the October 2006 update continuing.},
  author={Tony Messana},
  journal={Nephrology nursing journal : journal of the American Nephrology Nurses' Association},
  year={2006},
  volume={33 6},
  pages={
          660-3; quiz 664-5
        }
}
  • Tony Messana
  • Published in
    Nephrology nursing journal : journal of the…
    2006
The Centers for Medicare and Medicaid Services issued a revised erythropoietin claims monitoring policy that governs reimbursement for Epoetin alfa and darbepoetin alfa in patients on dialysis effective October 1, 2006. The new policy reinforces the upper Hb target level of 12.0 g/dL. However, the new provisions also allow increased latitude for making timely dose adjustments in response to the variability in Hb levels that occurs due to changes in patient status. 

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.